Health

CSOFT’s health blog aims to provide insight into complex diseases, treatment options and regulatory developments, and other prevalent health issues people face today.
Moderna Working on Improving COVID-19 Vaccine

Moderna Working on Improving COVID-19 Vaccine

Moderna, currently one of three companies granted emergency use authorization (EUA) by the U.S. Food and Drug Administration (FDA) for its COVID-19 vaccine, is continuing its efforts in improving the vaccine. Currently, the vaccine must be stored in cold temperatures;...

read more
Parkinson’s Clinical Trial Approved by FDA

Parkinson’s Clinical Trial Approved by FDA

The U.S. Food and Drug Administration (FDA) announced its approval of Hope Biosciences Stem Cell Research Foundation's (HBSCRF) Phase II double blind placebo controlled Parkinson's clinical trial. The clinical trial will test the efficacy and safety of multiple...

read more
FDA & CDC Lift Restrictions on J&J Vaccination

FDA & CDC Lift Restrictions on J&J Vaccination

The U.S. Food and Drug Administration (FDA) and the Center for Disease Control (CDC) lifted restrictions on the single-shot Johnson & Johnson vaccination for COVID-19 this past Friday (April 23) after the FDA's Advisory Committee on Immunization Practices (ACIP)...

read more
TGA Approves Global Sarcoma Therapy

TGA Approves Global Sarcoma Therapy

The Therapeutic Goods Administration (TGA) has approved the use of Global Sarcoma Therapy called YONDELISÒ, marketed by Specialised Therapeutics, for Australian patients afflicted with "unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior...

read more
India Sets New World Record of COVID-19 Cases

India Sets New World Record of COVID-19 Cases

India recorded today the highest number of COVID-19 cases in a day today (4/22) at 314,835 infections, surpassing the previous record from the United States at 297,430. The exponential rise in cases have caused fear regarding hospital oxygen supply levels to treat...

read more

Categories

ABOUT US

CSOFT Health Sciences has over 15 years of experience providing end-to-end translation and localization solutions for all stages of the product life cycle, from pre-clinical to post-launch. We also specialize in China market access consulting services, Asian regulatory and eCTD submissions. Our operation is compliant with ISO 17100 and certified by BSI in ISO 9001:2015 and ISO 13485:2016, providing customized solutions to meet the rigorous regulatory requirements in global submission. For more information, please visit: www.csoftintl.com